BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2441603)

  • 1. Elevated maternal serum alpha-fetoprotein levels and oligohydramnios: poor prognosis for pregnancy outcome.
    Dyer SN; Burton BK; Nelson LH
    Am J Obstet Gynecol; 1987 Aug; 157(2):336-9. PubMed ID: 2441603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated maternal serum alpha-fetoprotein, second-trimester oligohydramnios, and pregnancy outcome.
    Koontz WL; Seeds JW; Adams NJ; Johnson AM; Cefalo RC
    Obstet Gynecol; 1983 Sep; 62(3):301-4. PubMed ID: 6192373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data.
    Milunsky A; Jick SS; Bruell CL; MacLaughlin DS; Tsung YK; Jick H; Rothman KJ; Willett W
    Am J Obstet Gynecol; 1989 Aug; 161(2):291-7. PubMed ID: 2475017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated maternal serum alpha-fetoprotein with oligohydramnios: ultrasound evaluation and outcome.
    Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):337-41. PubMed ID: 2457190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a single antibody RIA assay for alpha-fetoprotein.
    Needleman SB; Goldstein AI; Johnson AM; Golubjatnikov R; Ward AM; Fifield R
    J Reprod Med; 1980 Sep; 25(3):101-7. PubMed ID: 6159471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between maternal serum and amniotic fluid alpha-fetoprotein in women undergoing early amniocentesis.
    Brumfield CG; Cloud GA; Davis RO; Finley SC; Hauth JC; Boots L
    Am J Obstet Gynecol; 1990 Sep; 163(3):903-6. PubMed ID: 1698336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation.
    Salafia CM; DeVore GR; Mainolfi E; Kelly J; Pezzullo JC; Rothlein R
    Am J Obstet Gynecol; 1993 Oct; 169(4):830-4. PubMed ID: 7694462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid alpha-fetoprotein levels and pregnancy outcome.
    Brumfield CG; Cloud GA; Finley SC; Cosper P; Davis RO; Huddleston JF
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):822-5. PubMed ID: 2445206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios.
    Los FJ; Beekhuis JR; Marrink J; Hagenaars AM; Reuss A; Sachs ES; Jahoda MG; Wladimiroff JW
    Prenat Diagn; 1992 Jan; 12(1):39-45. PubMed ID: 1372972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein in twin pregnancies uncomplicated by neural tube defect.
    Redford DH; Whitfield CR
    Am J Obstet Gynecol; 1985 Jul; 152(5):550-3. PubMed ID: 2409797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Fetoprotein and renal dysfunction of the fetus.
    Mühlhaus K; Peltner HU; Behrens O; Degenhardt F
    Am J Perinatol; 1991 Nov; 8(6):361-4. PubMed ID: 1726038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
    Huerta-Enochian G; Katz V; Erfurth S
    Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum.
    Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.
    Waller DK; Lustig LS; Cunningham GC; Golbus MS; Hook EB
    N Engl J Med; 1991 Jul; 325(1):6-10. PubMed ID: 1710779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal detection of neural tube defects. VI. Experience with 20,000 pregnancies.
    Milunsky A
    JAMA; 1980 Dec; 244(24):2731-5. PubMed ID: 6160265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
    Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
    Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage II ultrasound examination for the diagnosis of fetal abnormalities with an elevated amniotic fluid alpha-fetoprotein concentration.
    Hobbins JC; Venus I; Tortora M; Mayden K; Mahoney MJ
    Am J Obstet Gynecol; 1982 Apr; 142(8):1026-9. PubMed ID: 6176125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised maternal serum AFP, oligohydramnios and poor fetal outcome.
    Stirrat GM; Gough JD; Bullock S; Wald NJ; Cuckle HS
    Br J Obstet Gynaecol; 1981 Mar; 88(3):231-5. PubMed ID: 6162472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of maternal alpha-fetoprotein: a comparison of three radioimmunoassays.
    Freeman RW; Harbison RD
    Teratog Carcinog Mutagen; 1983; 3(5):407-20. PubMed ID: 6196850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
    Standing SJ; Brindle MJ; Macdonald AP; Lacey RW
    Br Med J (Clin Res Ed); 1981 Sep; 283(6293):705-7. PubMed ID: 6169386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.